India received $4.8 billion from 130 equity deals in July 2016.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

However there was a 16% y-o-y fall in deal volumes, primarily on account of a substantial decline in private equity (PE) investments, Grant Thornton analysts, Prashant Mehra said in a report.

“Overall deal activity in 2016 has remained stable with 3% increase in the deal values, driven by strong M&A growth and PE investments sustaining deal volumes,” the report stated.

The largest inbound deal came from the pharma, healthcare & biotech sector which contributed nearly 40% of total deal value. 

Among the mergers and acquisition (M&A) deals, Nirma Ltd topped the charts with acquisition of Lafarge cement assets garnering $1,400 million.

Fosun Pharmaceuticals took $1.3 billion in majority stake deal in the acquisition of Gland pharma.

There were large domestic transactions with overall values growing 1.7 times driven by three deals in the billion dollar club accounting for more than half of domestic deal values.

IT&ITES, energy & natural resources sector also witnessed big ticket deals while the startup sector saw higher volumes driven by increasing consolidation in the sector, the report added.

In line with previous trends, the month was dominated by investments in startups which contributed to 70% of total volumes and nearly 30% of values. Interestingly, more than 50% of investment volumes were towards early stage funding towards start-ups, the report added.
 

India saw the passage of GST bill post the close of July. 

This in turn is a significant step towards ease of doing business as well as boosting growth in the economy, the report stated.    

India was the top destination for private equity (PE) and venture capital (VC) investors in 2015, a report by Bain & Co. India Pvt. Ltd stated.

The country received a record $22.4 billion in investments in 2015, 31.8% more than the previous highest of $17 billion in 2007.